75 research outputs found
Whole-Body CT after Motor Vehicle Crash: No Benefit after High-Energy Impact and with Normal Physical Examination
Background Debate continues about the risks and benefits of systematic whole-body CT when no injury is clinically suspected. Risks of whole-body CT include high radiation exposure and iodine contrast agent, but its effectiveness in reducing mortality in low-risk motor vehicle crashes is unclear. Purpose To assess unsuspected injuries revealed at whole-body CT in patients following motor vehicle crash (MVC) meeting only kinetic elements of the Vittel criteria for the severity of trauma, with no evidence of trunk injury and a Glasgow Coma Scale score of 15. Materials and Methods This retrospective study included all consecutive adult patients who consulted an emergency department of a level 1 trauma center between August 2016 and July 2017 if they underwent whole-body CT for one or more kinetic elements of the Vittel criteria, had a normal examination of the trunk, and had a Glasgow Coma Scale score of 15. Data of the MVC mechanism and physical and biologic examinations were collected, as well as patient treatment data after whole-body CT. Whole-body CT examinations were read by two double-blinded readers to help detect unsuspected injuries. Results Ninety-three patients were included; 72 were men with a mean age of 30.8 years ± 12.0 (standard deviation). Sixty-nine patients were occupants of a car. Seventeen patients were hit by a car while on motorbikes, three while on bicycles, and four as pedestrians. Unsuspected injuries were depicted at 11 whole-body CT examinations: eight lung contusions, one acetabular fracture, one sternal fracture, and one adrenal hematoma. None of these injuries required a specific treatment. One patient with lung contusion of more than 30% of lung volume was followed without requiring further treatment. Conclusion In this population, whole-body CT did not lead to any change in patient treatment. These results suggest whole-body CT should not be systematically performed when no evidence of trunk injury is observed in patients following motor vehicle crash meeting only kinetic elements of Vittel criteria. © RSNA, 2019 See also the editorial by Munera and Durso in this issue
Longitudinal assessment of bleomycin-induced lung fibrosis by Micro-CT correlates with histological evaluation in mice
Analysis of body mass index, weight loss and progression of idiopathic pulmonary fibrosis
Background: Nintedanib is an approved therapy for idiopathic pulmonary fibrosis (IPF). Some patients treated with nintedanib experience weight loss. Exploratory data suggest that low body mass index or weight loss are associated with worse outcomes in patients with IPF. We investigated whether BMI at baseline or weight loss over 52 weeks was associated with FVC decline, or influenced the effect of nintedanib, in patients with IPF. Methods: Using pooled data from the two INPULSIS trials, we analysed the rate of decline in FVC (mL/yr) over 52 weeks in patients treated with nintedanib and placebo in subgroups by baseline BMI ( 5%) using random coefficient regression. Results: In the placebo group, the mean rate of FVC decline over 52 weeks was numerically greater in patients with lower baseline BMI (− 283.3 [SE 22.4], − 207.9 [20.9] and − 104.5 [21.4] in patients with BMI 5% than ≤5% weight loss over 52 weeks (− 312.7 [SE 32.2] versus − 199.5 [SE 14.4] mL/year). Nintedanib reduced the rate of FVC decline versus placebo in both subgroups by weight loss, with a greater treatment effect in patients with > 5% weight loss (interaction p = 0.0008). The adverse event profile of nintedanib was similar across subgroups. Conclusions: In patients with IPF, lower BMI and weight loss may be associated with faster decline in FVC. Nintedanib reduces the rate of FVC decline both in patients who lose weight on treatment and those who do not. Trial registration: ClinicalTrials.gov; Nos. NCT01335464 and NCT01335477; URL: www.clinicaltrials.gov
Magnetic resonance imaging in children: common problems and possible solutions for lung and airways imaging
Pediatric chest MRI is challenging. High-resolution
scans of the lungs and airways are compromised by long imaging
times, low lung proton density and motion. Low signal
is a problem of normal lung. Lung abnormalities commonly
cause increased signal intenstities. Among the most important
factors for a successful MRI is patient cooperation, so the long
acquisition times make patient preparation crucial. Children
usually have problems with long breath-holds and with the
concept of quiet breathing. Young children are even more
challenging because of higher cardiac and respiratory rates
giving motion blurring. For these reasons, CT has often been
preferred over MRI for chest pediatric imaging. Despite its
drawbacks, MRI also has advantages over CT, which justifies
its further development and clinical use. The most important
advantage is the absence of ionizing radiation, which allows
frequent scanning for short- and long-term follow-up studie
EACVI/EHRA Expert Consensus Document on the role of multi-modality imaging for the evaluation of patients with atrial fibrillation
Atrial fibrillation (AF) is the commonest cardiac rhythm disorder. Evaluation of patients with AF requires an electrocardiogram, but imaging techniques should be considered for defining management and driving treatment. The present document is an expert consensus from the European Association of Cardiovascular Imaging (EACVI) and the European Heart Rhythm Association. The clinical value of echocardiography, cardiac magnetic resonance (CMR), computed tomography (CT), and nuclear imaging in AF patients are challenged. Left atrial (LA) volume and strain in echocardiography as well as assessment of LA fibrosis in CMR are discussed. The value of CT, especially in planning interventions, is highlighted. Fourteen consensus statements have been reached. These may serve as a guide for both imagers and electrophysiologists for best selecting the imaging technique and for best interpreting its results in AF patients
Multimodal images integration for catheter ablation of ventricular tachycardia
International audienceRadiofrequency catheter ablation is an important therapeutic option for patients with recurrent ventricular tachycardia (VT). The procedure aims at cauterizing regions of the ventricle. A good knowledge of anatomical structures and tissues properties can improve procedure safety and efficacy. This work aimed at analysing the feasibility of a workflow based on multimodal image integration to assist the intervention. We focused here on a model including myocardial thickness and fibrosis extracted from late gadolinium enhanced MRI (LGE-MRI) sequence, and left ventricular anatomy segmented from multiphase computed tomography (CT). The produced model can be imported within Carto-3® system (Biosense Webster Inc, Diamond Bar, CA), the software used during the ablation procedure. Four patients cases have been included in this preliminary study. The four produced patient specific models have been validated by a clinician, and two of them have been integrated within Carto-3® system and used during the intervention. © 2017 IEEE Computer Society. All rights reserved
Pneumopathie d’hypersensibilité révélée par un syndrome de détresse respiratoire aiguë
National audienc
- …